New Drug Controller of India (DCGI) takes over

New Delhi: Dr Eshwar Reddy is the new Drug Controller of India (DCGI). He takes over the charge from Dr G.N. Singh.

Dr Reddy bucks the trend in the sense that he is not a political appointee. He is from within the department and is seized of a well thought out Pharma vision 2030.  Perhaps After a long time, he is a professional appointee as in the past most DCGI were political nominations from outside department. For long term Pharma vision, he is considered the most eligible one for this post.

Dr Reddy has leadership qualities and it is hugely hoped that he would come out with flying colours during his three month probation. Medical device sector has been his pet subject.

Rajiv Nath, Forum Coordinator, Association of Indian Medical device industry (AiMeD), has expressed utmost pleasure on his appointment and not being a political appointee. Dr Reddy was joint drug controller of India.

  • Related Posts

    • Pharma
    • April 16, 2024
    • 20 views
    Significant Decline In Pharma Deals In Q1

    NEW DELHI: The pharma and healthcare sector witnessed a significant 15% decline in volume in the first quarter this year, with 47 deals amounting to $ 409 million, as against the…

    • Pharma
    • April 16, 2024
    • 21 views
    Rise In AMR Is Leaving Doctors With Fewer Options In Drugs

    Ahmedabad: Imagine a bacterial infection with no known cure — a relentless adversary that defies conventional treatments and leads to prolonged illness and hospitalization. This was the condition of nine people…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Significant Decline In Pharma Deals In Q1

    Significant Decline In Pharma Deals In Q1

    Rise In AMR Is Leaving Doctors With Fewer Options In Drugs

    Rise In AMR Is Leaving Doctors With Fewer Options In Drugs

    CDSCO Releases Draft Guidance To Align New Drugs And Clinical Trials Rules And SUGAM For Stakeholder’s Comments

    CDSCO Releases Draft Guidance To Align New Drugs And Clinical Trials Rules And SUGAM For Stakeholder’s Comments

    Glenmark recalls 6,528 bottles of BP drug in US

    Glenmark recalls 6,528 bottles of BP drug in US

    Pharma Exports To US Surges 15% In 11 Months Of FY24

    Pharma Exports To US Surges 15% In 11 Months Of FY24

    CAHO Naa Patients Se Pyaar Hai

    CAHO Naa Patients Se Pyaar Hai